Biogen Uses its Own Superspreader Event to Aid COVID-19 Research

The biotech company Biogen allows scientists to study the immune responses to the coronavirus among infected Biogen employees and their contacts. Researchers at the Broad Institute would collect blood and clinical history from Biogen volunteers.

Read More

 


Sources